Emvision Medical Devices Ltd - Asset Resilience Ratio
Emvision Medical Devices Ltd (EMV) has an Asset Resilience Ratio of 0.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Emvision Medical Devices Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Emvision Medical Devices Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Emvision Medical Devices Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Emvision Medical Devices Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Emvision Medical Devices Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$14.59K | 0.06% |
| Total Liquid Assets | AU$14.59K | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Emvision Medical Devices Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Emvision Medical Devices Ltd Industry Peers by Asset Resilience Ratio
Compare Emvision Medical Devices Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Emvision Medical Devices Ltd (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Emvision Medical Devices Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.47% | AU$73.65K ≈ $52.11K |
AU$15.57 Million ≈ $11.02 Million |
+0.18pp |
| 2024-06-30 | 0.30% | AU$70.94K ≈ $50.20K |
AU$23.97 Million ≈ $16.96 Million |
-2.38pp |
| 2023-06-30 | 2.68% | AU$308.44K ≈ $218.24K |
AU$11.52 Million ≈ $8.15 Million |
+0.62pp |
| 2022-06-30 | 2.06% | AU$175.12K ≈ $123.91K |
AU$8.51 Million ≈ $6.02 Million |
-- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more